Date(s) - 02/04/2015
Dr. Stanton Rowe
Chief Scientific Officer, Corporate Vice President, Advanced Technology at Edwards Lifesciences, a $2B+ medical device developer/manufacturer
Has been in leadership position of 3 of the 4 most important cardiovascular device development over the last 30 years; balloon angioplasty and stents, bare metal and drug-eluting stents, and transcatheter valve technology
Will discuss the process of device innovation, biomedical development of the transcatheter valve from inception to a clinical standard
Seminar reception (pizza lunch served) starts at 11:30am and the seminar starts at 12:00pm.